ECHINOMYCIN (NSC 526417) IN RECURRENT AND METASTATIC NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

被引：6

作者：

MUSS, HB

BLESSING, JA

HANJANI, P

MALFETANO, JH

KEMP, GM

WEBSTER, K

机构：

[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103

[2] ROSWELL PK CANC INST,GYNECOL ONCOL GRP,BUFFALO,NY

[3] TEMPLE UNIV,HLTH SCI CTR,PELVIC ONCOL SECT,PHILADELPHIA,PA 19140

[4] ALBANY MED CTR HOSP,DEPT OBSTET & GYNECOL,ALBANY,NY 12208

[5] EASTERN VIRGINIA MED SCH,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,NORFOLK,VA 23501

[6] CLEVELAND CLIN EDUC FDN,DEPT GYNECOL,CLEVELAND,OH 44106

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1992年 / 15卷 / 04期

关键词：

ECHINOMYCIN; NONSQUAMOUS CELL CARCINOMA; CERVIX CANCER; PHASE-II TRAIL;

D O I：

10.1097/00000421-199208000-00019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Eighteen evaluable patients with recurrent or metastatic nonsquamous carcinoma of the uterine cervix were treated with 1,500-mu-g/m2 of echinomycin every 4 weeks. Seven patients had received prior chemotherapy. There was one complete response (5.6%), 95% confidence interval for response of 0-27%. The major toxicity was nausea and vomiting, which was moderate to severe in eight patients. Myelosuppression was minimal. Echinomycin in this dose and schedule displays minimal activity in patients with advanced nonsquamous carcinoma of the cervix.

引用

页码：363 / 364

页数：2

共 50 条

[1] ECHINOMYCIN (NSC-526417) IN RECURRENT AND METASTATIC SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP (GOG)
MUSS, HB
BLESSING, JA
EDDY, GL
MCGEHEE, R
INVESTIGATIONAL NEW DRUGS, 1992, 10 (01) : 25 - 26
[2] ECHINOMYCIN (NSC-526417) IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
MUSS, HB
BLESSING, JA
MALFETANO, J
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (03): : 191 - 193
[3] ECHINOMYCIN IN RECURRENT AND METASTATIC ENDOMETRIAL CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
MUSS, HB
BLESSING, JA
DUBESHTER, B
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 492 - 493
[4] ECHINOMYCIN (NSC-526417) IN ADVANCED OVARIAN-CANCER - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
MUSS, HB
BLESSING, JA
BAKER, VV
BARNHILL, DR
ADELSON, MD
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 299 - 301
[5] A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix - A gynecologic oncology group study
Malfetano, JH
Blessing, JA
Homesley, HD
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 495 - 497
[6] A PHASE-II TRIAL OF ECHINOMYCIN IN METASTATIC CERVIX CARCINOMA
HAKES, T
MARKMAN, M
PHILLIPS, M
INVESTIGATIONAL NEW DRUGS, 1990, 8 (03) : 311 - 312
[7] AMINOTHIADIAZOLE (NSC-4728) IN PATIENTS WITH ADVANCED NONSQUAMOUS CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC ONCOLOGY GROUP
ASBURY, RF
BLESSING, JA
DISAIA, PJ
MALFETANO, J
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (05): : 375 - 377
[8] A Phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix - A gynecologic oncology group study
Asbury, R
Blessing, JA
Look, KY
Buller, R
Lucci, JA
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (06): : 626 - 627
[9] Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
Santin, A.
Patricia, G.
Sill, M.
McMeekin, D.
Leitao, M.
Brown, J.
Sutton, G.
Van Le, L.
Boardman, C.
GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S18 - S18
[10] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
SLAYTON, RE
BLESSING, JA
HOMESLEY, HD
CANCER TREATMENT REPORTS, 1984, 68 (12): : 1513 - 1514

← 1 2 3 4 5 →